Latest from Gallop Press Releases Press Releases News Archive Press Release September 21, 2026 PureTech Announces Successful End-of-Phase 1 Meeting with U.S. FDA and Receipt of Fast Track Designation for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplastic Syndromes (HR-MDS) Press Release September 21, 2026 Read more → Press Release September 21, 2026 Press Release April 22, 2026 PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory (R/R) High-Risk (HR) Myelodysplastic Syndrome (MDS) and R/R Acute Myeloid Leukemia (AML) Press Release April 22, 2026 Read more → Press Release April 22, 2026
